share_log

Evelo Biosciences | EFFECT: Others

Evelo Biosciences | EFFECT:其他

美股sec公告 ·  03/11 06:06
Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
美国证券交易委员会(SEC)宣布了Evelo Biosciences, Inc.的生效通知。该通知的日期为2024年3月8日,表明该公司提交的材料已被接受并现已生效。提交类型为 POS AM,注册号为 0001193125-24-016886。由CIK 0001694665确认的Evelo Biosciences已以333-273869的编号提交了申请。
美国证券交易委员会(SEC)宣布了Evelo Biosciences, Inc.的生效通知。该通知的日期为2024年3月8日,表明该公司提交的材料已被接受并现已生效。提交类型为 POS AM,注册号为 0001193125-24-016886。由CIK 0001694665确认的Evelo Biosciences已以333-273869的编号提交了申请。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息